Targeted Pathway Inhibition in Patients With Pancreatic Cancer

Clinical trial NCT04005690 · RECRUITING

Trial details

NCT number: NCT04005690
Sponsor: OHSU Knight Cancer Institute
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Locally Advanced Pancreatic Ductal Adenocarcinoma Metastatic Pancreatic Ductal Adenocarcinoma Stage II Pancreatic Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8 Unresectable Pancreatic Ductal Adenocarcinoma Borderline Resectable Pancreatic Ductal Adenocarcinoma Resectable Pancreatic Ductal Adenocarcinoma

Start date: 2019-08-01
Primary completion: 2026-06-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.